Literature DB >> 15196600

Psychosocial functioning in patients with treatment resistant depression.

Timothy Petersen1, George I Papakostas, Yasmin Mahal, Wendy M Guyker, Erin C Beaumont, Jonathan E Alpert, Maurizio Fava, Andrew A Nierenberg.   

Abstract

BACKGROUND: Depression is a disorder that causes disability, with a profound adverse impact on all areas of psychosocial functioning. This is particularly true for those with treatment resistant depression (TRD). However, to date, no systematic assessments of psychosocial functioning for patients with TRD have been conducted.
METHODS: In the present study, we used the Longitudinal Interval Follow-up Evaluation (LIFE) scale to measure psychosocial functioning in 92 patients with TRD. These patients met formal criteria for TRD and were part of a clinical trial examining the efficacy of lithium augmentation of nortriptyline.
RESULTS: Clinicians rated this sample of patients as experiencing mild to moderate impairment in work-related activities, good to fair interpersonal relations, poor level of involvement in recreational activities, and mild impairment of ability to enjoy sexual activity. Patients and clinicians rated global social adjustment as poor.
CONCLUSIONS: Patients with formally defined TRD experience significant impairment in psychosocial functioning. In this sample a tendency existed for both clinicians and patients to assign more severely impaired global ratings when compared with ratings for specific functional areas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196600     DOI: 10.1016/j.eurpsy.2003.11.006

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  5 in total

1.  Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial.

Authors:  Eric J Lenze; Nuri B Farber; Evan Kharasch; Julie Schweiger; Michael Yingling; John Olney; John W Newcomer
Journal:  World J Biol Psychiatry       Date:  2016-02-26       Impact factor: 4.132

2.  A clinical risk stratification tool for predicting treatment resistance in major depressive disorder.

Authors:  Roy H Perlis
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

Review 3.  Vagus nerve stimulation: can it be used in adolescents or children with treatment-resistant depression?

Authors:  Zheya Jenny Yu; Ronald A Weller; Kendra Sandidge; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

4.  Utility of the Berlin questionnaire for predicting obstructive sleep apnea in individuals with treatment-resistant depression.

Authors:  Michael W Best; Michael Fitzpatrick; Roumen Milev; Christopher R Bowie; Ruzica Jokic
Journal:  Sleep Breath       Date:  2013-04-11       Impact factor: 2.816

5.  Comparative Study of Cognitive Function Between Treatment-Resistant Depressive Patients and First-Episode Depressive Patients.

Authors:  Dongping Rao; Guiyun Xu; Zenghong Lu; Huiwei Liang; Kangguang Lin; Muni Tang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-09       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.